UCB’s Cough Medicine Tussionex Raises Safety Concerns, FDA Says

March 7 (Bloomberg) -- UCB SA's prescription cough medicine Tussionex has prompted ``safety concerns'' at the U.S. Food and Drug Administration, an agency spokeswoman said.